MedTrace Logo

The Effect of Pericapsular Nerve Group Block With Different Local Anesthetic Volumes

NCT07666737 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-24

No results posted yet for this study

Summary

Early postoperative pain following shoulder surgery is a significant clinical problem for both patients and orthopedic surgeons. Effective pain control is crucial for improving postoperative comfort and optimizing rehabilitation. Pericapsular nerve group block (PENG) is a regional anesthesia method that has recently gained attention due to its lack of motor block and absence of pulmonary complications. The aim of this study is to evaluate the effect of PENG block, applied at two different volumes, on postoperative pain and opioid consumption in patients undergoing arthroscopic shoulder surgery.

Conditions

  • Pericapsuler Nerve Group Block
  • Postoperative Pain

Interventions

PROCEDURE

pericapsular nerve group (PENG) block

During PENG block application; the patient's arm was rotated externally and abducted at 45 degrees. A longitudinal linear ultrasound probe was placed between the coracoid and humeral head. After identifying the humeral head, the tendon of the subscapular muscle, and the deltoid muscle above it, a 50 mm needle was inserted using the "in-plane" technique. After the needle tip was placed above the bone below the subscapularis tendon, a local anesthetic solution was injected.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-01-01
Completion
2027-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07666737 on ClinicalTrials.gov